Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT04196842 · ClinicalTrials.gov registry record · NA

Heart Failure Precision Medicine Study

A NA study of Heart Failure, sponsored by University of California, Davis.

Recruiting
Registry status
NA
Development phase
100
Enrollment target
1
Study location

NCT04196842 is a NA study of Heart Failure that is actively recruiting participants, run by University of California, Davis. The registered enrollment target is 100 participants, below the 2,049-participant average among 397 other Heart Failure trials with a reported enrollment target (95% lower). The trial reports 1 study location across 1 state.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT04196842, a NA study of Heart Failure, is actively recruiting participants, sponsored by University of California, Davis.

RECRUITING
Registry status
NA
Development phase
100 participants
Enrollment target
1
Study location

Study Summary

The study aims to test the hypothesis that multi-omics studies can identify Heart Failure profiles at risk of adverse outcomes and evaluate a telemonitoring intervention in the optimization of guideline-directed medical therapy.

Conditions Studied

Interventions

  • DEVICE Telemonitoring devices

Study Locations (1)

California

  • UC Davis Medical Center - Sacramento

Trial Details

FieldValue
Enrollment Target 100 participants
Start Date 2019-10-16
Est. Completion 2026-10-16
Phase NA

Sponsor

University of California, Davis

657 total trials

What the Registry Record Tells You About NCT04196842

The ClinicalTrials.gov registry entry for NCT04196842 describes a study currently listed as recruiting, categorized as NA. The registered enrollment target is 100 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 2,049-participant average among 397 other Heart Failure trials with a reported enrollment target (95% lower). The listed sponsor is University of California, Davis, which has 657 total studies on file at ClinicalTrials.gov.

The record links to 1 condition, with Heart Failure appearing as the primary indexed condition, and to 1 intervention - of which Telemonitoring devices is the first listed.

NCT04196842 reports 1 study location spanning 1 distinct geographic area - top geographies include California.

Frequently Asked Questions

What is clinical trial NCT04196842 about?

NCT04196842 is a clinical study titled "Heart Failure Precision Medicine Study". The study aims to test the hypothesis that multi-omics studies can identify Heart Failure profiles at risk of adverse outcomes and evaluate a telemonitoring intervention in the optimization of guideline-directed medical therapy.

What is the current status of trial NCT04196842?

This trial is currently recruiting. It is a NA study. The enrollment target is 100 participants. The study started on 2019-10-16. Estimated completion is 2026-10-16.

What conditions does trial NCT04196842 study?

This clinical trial studies the following conditions: Heart Failure.

What interventions are being tested in trial NCT04196842?

The interventions under investigation include: Telemonitoring devices (DEVICE).

Who is sponsoring clinical trial NCT04196842?

This trial is sponsored by University of California, Davis, which has 657 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT04196842 being conducted?

This trial has 1 study location across California. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Heart Failure

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.